Gonzalez Gonzalez D, van Dijk J D, Blank L E, Rümke P
Radiother Oncol. 1986 Jun;6(2):105-13. doi: 10.1016/s0167-8140(86)80016-0.
In 24 patients with metastatic malignant melanoma, combined treatment with radiation and hyperthermia was administered to 38 localizations, radiation alone to 8 comparative localizations and hyperthermia alone to 3 localizations. Hyperthermia was administered during one hour by using a 433 MHz microwave generator. The heat treatment was given within 30 min following irradiation. Although an intratumoral temperature of 43 degrees C was aimed, considerable variations occurred during one session and from session-to-session. Radiation schedules consisted in either one large fraction (6-8 Gy) once a week in 14-21 days or two fractions (4-5 Gy) twice a week in 21 days. In the group of patients receiving irradiation once a week, three heat treatments were administered. In the twice-a-week radiation schedule, six heat sessions were given. The overall complete response (CR) rate in patients receiving combined treatment was 50%. In the group of patients treated with hyperthermia and irradiation schedules of 8 Gy per fraction, the CR rate was 83%. Irradiation alone achieved 38% CR rate but some of these CR relapsed during follow-up whereas the comparative area treated with radiation and heat remained under control at this time. The lesions treated with heat alone did not show any response to treatment. Enhancement of the acute skin reactions was generally observed. However, because the total doses were relatively low, this enhancement did not constitute a clinical problem. CR appears to occur more frequently in small tumor sizes. The highest and lowest temperature ever registered during any session of hyperthermia did not seem to correlate with the tumor response.
在24例转移性恶性黑色素瘤患者中,对38个部位进行了放疗与热疗联合治疗,对8个对照部位仅进行放疗,对3个部位仅进行热疗。使用433MHz微波发生器进行1小时的热疗。热疗在放疗后30分钟内进行。尽管目标是肿瘤内温度达到43摄氏度,但在一个疗程内以及不同疗程之间仍出现了相当大的变化。放疗方案包括在14 - 21天内每周一次大剂量分割(6 - 8Gy),或在21天内每周两次小剂量分割(4 - 5Gy)。在每周放疗一次的患者组中,进行了三次热疗。在每周放疗两次的方案中,进行了六次热疗。接受联合治疗的患者总体完全缓解(CR)率为50%。在接受热疗和每次分割剂量为8Gy的放疗方案的患者组中,CR率为83%。单纯放疗的CR率为38%,但其中一些CR在随访期间复发,而接受放疗和热疗的对照区域此时仍处于控制之下。仅接受热疗的病变对治疗无任何反应。通常观察到急性皮肤反应增强。然而,由于总剂量相对较低,这种增强并不构成临床问题。CR似乎在肿瘤较小的情况下更频繁地发生。在任何热疗疗程中记录到的最高和最低温度似乎与肿瘤反应无关。